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Single-cell analysis is a rapidly evolving approach to characterize genome-scale molecular information at the
individual cell level. Development of single-cell technologies and computational methods has enabled systematic
investigation of cellular heterogeneity in a wide range of tissues and cell populations, yielding fresh insights into
the composition, dynamics, and regulatory mechanisms of cell states in development and disease. Despite
substantial advances, significant challenges remain in the analysis, integration, and interpretation of single-cell
omics data. Here, we discuss the state of the field and recent advances and look to future opportunities.Background
Cell-to-cell variation is a universal property of multi-
cellular organisms, which contain diverse cell types
characterized by different functions, morphologies, and
gene expression profiles. Even within any single tissue,
no matter how apparently homogeneous, there is a
diverse population of cells, all of which represent differ-
ent manifestations of that tissue type. Investigation of
tissues or cell populations is inherently limited by the
fact that the readout of any pooled assay that uses bulk
tissue represents a weighted average of that population’s
cellular constituents. Intrinsic cellular heterogeneity is
obscured in the typical ensemble studies on which the
canon of modern biology and medicine is constructed.
Consider, for example, the diverse repertoire of cells
present in the three most rapidly self-renewing tissues in
mammals: blood, skin, and the intestinal epithelium.
Although the trajectory from stem to terminally differ-
entiated cell is almost certainly a continuum of highly
variable states, our limited understanding forces us to
regard known stem and progenitor cell populations as
discrete and stable entities. Even in post-mitotic tissues
such as the adult brain, the differentiated cell states* Correspondence: gcyuan@jimmy.harvard.edu
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tories may also appear as a continuum. The diversity of
cellular states is not only caused by their own inherent
cell-to-cell variability, but also influenced by interactions
among tens or even hundreds of distinct cells. These
considerations question the precise boundary of a cell type
and point to the need for single-cell analysis to dissect the
underlying complexity and the empirical reality of stable
and distinct cell states.
The past few years have seen the introduction of tech-
nologies that provide genome-scale molecular information
at the resolution of single cells, providing unprecedented
power for systematic investigation of cellular heterogen-
eity in DNA [1, 2], RNA [3], proteins [4], and metabolites
[5]. These technologies have been applied to identify pre-
viously unknown cell types and associated markers [6–8]
and to predict developmental trajectories [9–13].
Beyond expanding the catalog of mammalian cell
states and identities, single-cell analyses have challenged
prevailing ideas of cell-fate determination [14–19] and
opened new ways of studying the mechanisms associated
with disease development and progression. For example,
single-cell DNA sequencing (scDNA-seq) has revealed
remarkable cellular heterogeneity inside each tumor,
significantly revising models of clonal evolution [20–22],
whereas single-cell RNA sequencing (scRNA-seq) has
shed new light on the role of tumor microenvironments
in disease progression and drug resistance [23].le is distributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
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of cells in a multi-cellular organism collectively requires
not only experimental methods that are considerably better
than existing platforms, but also synchronous development
of computational methods that can be used to derive
useful insights from complex and dense data on large
numbers of diverse single cells. Several recent papers have
discussed various challenges critical to advance the incipi-
ent field of single-cell analysis [24–27]; here we expand on
these discussions with a focus on looking to the future.
Current challenges in analyzing single-cell data
While many methods have been successfully used for the
analysis of genomic data from bulk samples, the relatively
small number of sequencing reads, the sparsity of data,
and cell population heterogeneity present significant
analytical challenges in effective data analysis. Recent ad-
vances in computational biology have greatly enhanced
the quality of data analyses and provided important new
biological insights [24–27].
Data preprocessing
The goal of data preprocessing is to convert the raw mea-
surements to bias-corrected and biologically meaningful
signals. Here we focus on scRNA-seq, which has become
the primary tool for single-cell analysis. Gene expression
profiling by scRNA-seq is inherently noisier than bulk
RNA-seq, as vast amplification of small amounts of start-
ing material combined with sparse sampling introduce
significant distortions. A typical single-cell gene expression
matrix contains excessive zero entries. The limited
efficiency of RNA capture and conversion rate combined
with DNA amplification bias may lead to significant
distortion of the gene expression profiles. On one hand,
even transcripts that are expressed at a high level may
occasionally evade detection altogether, resulting in false-
negative errors. On the other hand, transcripts that are
expressed at a low level may appear abundant due to amp-
lification biases. These errors artificially inflate the estimate
of the cell-to-cell variability. While a number of methods
have been developed to address this issue [28–30], man-
aging dropout events continues to be a challenge. Another
source of technical variation is the batch effect, which can
be introduced when cells from one biological group are
cultured, captured, and sequenced separately from cells in
a second condition. If a scRNA-seq experiment is designed
improperly, the results can be significantly affected by
batch effects [31]. Furthermore, high throughput technolo-
gies typically involve multiplexing of thousands or more
barcode sequences. Errors in demultiplexing may be
caused by barcode impurities or external background, and
dealing with them has become increasingly challenging as
thousands or more cells are multiplexed by recent tech-
nologies. Finally, the cell-to-cell variation may also beattributed to cell size, cell cycle state, and other factors that
are irrelevant for cell type identification. Statistical models
have been developed to remove such confounding factors
[27]. Together, these technical artifacts pose important
challenges for data calibration and interpretation.
The entanglement of technical and biological variation
poses a significant challenge for evaluating data reproduci-
bility. One approach to directly measure technical variabil-
ity is to use dilute bulk RNA to approximately single-cell
levels (~10–50 pg of total RNA) [32, 33]. However, this
approach has at least two significant limitations. First,
RNA purification leaves out cellular factors that may
impede RNA isolation and amplification. Second, accurate
dilution up to single-cell levels is technically challenging.
Another approach is to use external spike-ins, such as
ERCC [34]. However, this approach also has a number of
limitations [35]. First, the spike-in probes typically have
different molecular properties to the RNA molecules of
interest. Second, the spike-in probes interact differently
with respect to different molecular biology protocols.
Furthermore, the dynamic range of spike-in sets like
ERCC is often not optimized for the dynamic range of a
typical single-cell transcriptome (~103–104). As such,
there is a great need to develop better-controlled methods
for separating technical and biological variation. Consider-
ing these limitations, targeted approaches aimed at precise
quantification of key pathways may provide more bio-
logical insights in some applications.
Lack of spatial-temporal context
Single-cell DNA-based and scRNA-based assays often
contain the following steps: cell isolation; cell sorting; and
library preparation and sequencing. During this process,
cells are isolated from their local environment and
destroyed prior to profiling. These “snapshots” lose im-
portant contextual information regarding both a cell’s
spatial environment and position within a trajectory of
dynamic behavior [25]. Both sources of information are
crucial to interpret the precise state of a cell at the time
point of its isolation (and usually destruction).
Future directions
In situ transcriptomic analysis
To preserve spatial information, a transcriptome can be
profiled in situ in fixed cells and tissues, using either in
situ hybridization (ISH) or sequencing. Single molecule
florescence in situ hybridization (smFISH) provides a
powerful tool for detecting individual transcripts [36, 37].
Using super-resolution microscopy [38, 39], this was
extended to image over a dozen messenger RNA (mRNA)
in situ regardless of transcript density [40]. More recently,
a temporal barcoding scheme was developed that scales
exponentially with the number of hybridizations, called
sequential FISH (seqFISH) [41]. In parallel, in situ
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transcripts in tissue sections [42, 43], which has broad
coverage but lower efficiency compared to FISH-based
methods. More recently, a Hamming distance 2-based
error correcting barcode system called merFISH [44] was
developed and can be applied to long transcripts (>3 kb).
This technology has recently been extended to detect 130
mRNA species [45]. Fundamentally, because of high back-
ground in tissues, smFISH-based methods are difficult to
apply directly for detection of mRNAs in tissues.
An amplified version of seqFISH [46], based on
hybridization chain reaction (HCR) [47], allows robust
detection of mRNAs in tissues and thick cleared brain
samples. Combining amplification and a simple one-
drop tolerant error correction scheme, this technology
was applied to profile up to 249 genes, with each mRNA
detected at ~80% efficiency, in over 15,000 cells in the
mouse brain to resolve the structural organization of the
hippocampus with single-cell resolution [48]. The
authors identified distinct layers in the dentate gyrus
corresponding to the granule cell layer and the subgra-
nular zone. They also found that the dorsal CA1 is rela-
tively homogeneous at the single-cell level, while ventral
CA1 is highly heterogeneous. For imaging large samples,
such as the brain, imaging speed is rate limiting, rather
than the switching time between hybridizations. This is
because one can toggle between two samples on the
microscope, one that is being imaged and another that is
being hybridized. Faster imaging modalities such as lat-
tice lightsheet [49] and faster cameras can enable higher
throughput in the number of imaged cells.
Future work in spatial genomics will take several
directions. First, to combine spatial transcriptome data
with scRNA-seq data, one can take an approach where
cell states are defined by RNA-seq and then mapped
onto the spatial images and transcription profiles deter-
mined by spatial transcriptome data [50]. Second, to in-
crease the optical space available in each cell and allow
more mRNAs to be resolved spatially, expansion micros-
copy [51] can physically enlarge the tissue sample. An
alternative image correlation approach [52] can also allow
dense transcripts to be decoded. Lastly, analysis of in situ
transcriptomic data requires development of new compu-
tational methods, for example, to automatically detect
spatial patterns from combinations of multiple genes.
Live imaging transcriptomic analysis
Cellular and molecular behaviors are highly dynamic
and constantly changing. These dynamic behaviors
greatly complicate the interpretation of snapshot single-
cell analyses because individual cells will differ in their
molecular state not only from other cells, but even from
themselves if analyzed at a different time point [25]. Im-
portantly, these dynamics may not represent noise, butrather a basis for important regulatory mechanisms con-
trolling cell identity, so it is important to quantify dynamic
changes and to understand their relevance [53]. Unfortu-
nately, it is also much more difficult than static snapshot
analyses. Cells must be kept alive and unchanged during
the continuous and sometimes very long non-invasive
analysis of their behaviors. The acquisition, handling, and
analysis of time-resolved single-cell data then require
specialized technical and theoretical approaches. Not only
are the requirements for robustness of data acquisition
technologies such as live imaging much higher than for
snapshot analyses, but the resulting large and complex
volumes of data require specialized solutions. These differ
from tools available to analyze snapshot data and often
require self-made custom developments. This holds true
for the required theoretical algorithms and for user-
friendly implementation [25].
Lineage tracing
The objective of lineage tracing is to label the progeny
of individual cells using molecular markers and use
such information to reconstruct the developmental
trajectories. Recently, high-throughput lineage-tracing
methods have been developed using CRSIPR/Cas9-
based multiplexing DNA barcodes synthesis [54–58].
These barcodes are stably registered in the genome and
inherited during cell division and differentiation. Add-
itional mutations are cumulated over time, through ei-
ther combinatorial editing at multiple guide RNA
(gRNA) target loci [54, 55, 57] or by sequential editing
at a single locus [56, 58]. In the latter approach, the
investigators introduced genetic mutations at the
Streptococcus pyogenes gRNA-encoding sequence to cir-
cumvent the requirement of the PAM motif in gRNA
recognition, enabling the resulting gRNA to repeatedly
target its own locus. In addition, the DNA barcodes can
be sequenced in situ, thereby preserving the spatial infor-
mation [58]. Some of the aforementioned technologies
have been applied to study developmental loci [54, 55, 57]
and immune response [56]. In one study [54], the investi-
gators traced the cell lineages in zebrafish and found that
the majority of cells in each organ are derived from a
small number of progenitor cells, whereas different pro-
genitors are biased toward different germ layers and
organs. Similar results are reported in an independent
study [55]. These lineage-tracing technologies will likely
have wide-ranging applications in mapping developmental
and disease-progression trajectories.
Single-cell multi-omics
While significant effort has been dedicated to improving
the quality and throughput of various omic assays, work
is also ongoing to develop methods to profile multiple
sources of information in the same cells. Multi-omics
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and can provide insights into regulatory mechanisms. For
example, genomic DNA and mRNA transcripts from the
same cells can be quantified by either physical separation
[59] or pre-amplification [60], followed by high through-
put sequencing. In the former, extracted genomic DNA
can be further processed by bisulfite conversion, leading
to simultaneous quantification of the methylome and
transcriptome [61, 62]. Bioinformatic analysis of the bisul-
fite sequencing data can further detect genetic informa-
tion [63, 64]. Protein and transcriptome have also been
measured in the same cells [65]. Multi-omic methods
applied to single cells have revealed some surprises. For
example, profiling DNA and RNA variability in single
acute lymphoblastic leukemia cells suggests that genetic
heterogeneity is not responsible for the diverse response
of drug treatment (Enver, unpublished).
Recent technologies have moved even beyond single
cells to investigate sub-cellular localization of biologic-
ally active molecules. For example, nanoliter-scale cell
fractionation or micro-manipulation has been applied to
measure subcellular information within single cells [66].
On a different front, super-resolution imaging has been
applied to map the nuclear compartmentalization of
chromatin domains [67]. These subcellular data provide
new insights into the precise mechanisms of various cellu-
lar processes. Ultimately, we may be able to understand
phenotypic differences between genetically identical cells
in terms of such variations in subcellular organization.
Modeling and predictions
Different cell types usually arise from a linear hierarchy
of differentiation stages and one goal of single-cell ana-
lysis is to identify previously unknown cell types and
lineage relationships. Numerous methods have been de-
veloped to isolate similar cell types from single-cell gene
expression data [7, 50, 68, 69]. Furthermore, additional
methods have been developed to specifically detect rare
cell subpopulations [70, 71]. To compensate for the
dropout effect, methods have also been developed to im-
pute gene expression based on similar cell types [72].
Single-cell analysis has helped refine traditional views
of cell differentiation. For example, a number of studies
[14–16, 73] report evidence to suggest that megakaryo-
cytes emerge at a “high” level, approximating that of the
hematopoietic stem cell (HSC); this insight challenges
the prevailing model that the megakaryocytic lineage
emerges late in the differentiation cascade. The cell
states defined by transcriptomic patterns are surprisingly
continuous instead of forming distinct, transcriptionally
defined groups [15, 74]. This apparent continuity of cell
states poses practical challenges for cell annotation and,
conceptually, implies a need for significant revisions to
current models of cell-lineage hierarchy.Data from single-cell studies have enabled the devel-
opment of mathematical models that represent the
distribution of cell states as one sampled from a dynamic
system [11, 17, 19, 73]. In this view, cell types are mod-
eled as “attractors” [75], stable states that are determined
by the underlying gene regulatory networks and some-
times referred to as the energy landscape. In some
models, stochastic fluctuation, due to either intrinsic or
extrinsic noise, may facilitate dispersion and transition
between attractors [11]. Although complex, these math-
ematical models can be used not only to explain the
continuity of cell states but also, in some cases, to pre-
dict the initiation events during cell differentiation,
thereby providing mechanistic insights [11]. In a similar
way, the hierarchy of cell states can be measured by en-
tropy, which has been applied to inform cell differenti-
ation directions [76, 77]. These new methods have
opened up new ways to think about cell states, not as
discrete entities, but as a continuum. To connect these
two viewpoints, it is critical to determine with high pre-
cision the level of natural variation that defines the same
cell type and distinguish this from the changes linked to
functional state transitions. A major obstacle to achiev-
ing this goal is that the resolution of cell-state identifica-
tion is limited by the quality of the underlying scRNA-
seq data, which varies greatly depending on sequencing
depth and other factors. Such differences have contributed
to the debate over the organizing structure of the
hematopoietic lineage hierarchy [15, 16].
Functional validation
As single-cell data continue to grow in quality and quan-
tity, new cell states, lineages, and associated markers are
being identified at an accelerating rate. It is important to
recognize that such findings are typically based on cor-
relative analyses and that their functional relevance
needs to be carefully evaluated through further experi-
mental validation.
A first level of validation is to utilize the identified
markers to label the predicted cell type and visualize it
in its original tissue. For example, unsupervised cluster-
ing of 25,000 single-cell transcriptomes identified 15
types of bipolar neurons [8]. The authors identified cell
type-specific markers and fluorescently labeled the pre-
dicted cell types by DNA FISH. They found that the
spatial organization of these predictive cell types is
restricted to definitive layers and that different cell types
display distinct morphologies, thereby supporting their
functional identity.
A deeper level of validation requires design of func-
tional assays to demonstrate that a predicted cell type
has unique properties. For example, single-cell analysis
showed that common myeloid progenitors (CMP) occur
in two varieties associated with differential expression of
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investigators found that CD55+ CMP produce predom-
inantly erythroid and megakaryocytic (MegE) colonies,
whereas few MegE colonies are formed from CD55–
CMP, indicating these two subpopulations are function-
ally different. A similar strategy has been applied to
compare the functional difference between HSC subpop-
ulations, termed MolO and NoMO [78]. These investi-
gators found that MolO cells were enriched for higher
than average CD150 and Sca-1 surface marker expres-
sion and lower than average CD48 expression.
In the same vein, engineered animal models can allow
isolation of cell populations and functional testing. For
example, comparative scRNA-seq analysis between HSCs
from young and old mice identified a gene signature asso-
ciated with the MegE lineage [79]. By using a transgenic
mouse strain carrying a VWF-EGFP reporter, the authors
verified an increased bias toward platelet-priming HSCs in
old mice.
Combining scRNA-seq- and CRISPR/cas9-based
perturbations
CRISPR/Cas9-based genetic screens have been widely
used to systematically characterize gene functions [80,
81]. Recently, this technique has been combined with
scRNA-seq analysis [82–85], thereby greatly increasing
the throughput of functional readouts. In these studies,
gene activities are disrupted by either genetic mutations
[82, 83, 85] or epigenetic inhibition [84]. gRNA-specific
reporter transcripts are synthesized, which can be de-
tected along with the mRNAs by scRNA-seq sequencing.
By varying the concentration of the gRNA-containing
vectors, the technique can be used to study the gene
function either in isolation or in combination. In one
study [82], the investigators applied this technology to
analyze the effects of 24 TFs in mediating the immune
response of dendritic cells. They found that the TFs
form distinct modules, each targeting a common set of
gene programs. Further analysis detected significant gen-
etic interactions among a subset of TFs. In another study
[83], the engineered hematopoietic progenitor cells were
injected into wild-type recipient mice to evaluate their
effect in hematopoiesis. This allowed them to identify a
previously unknown role of Cebpb in regulating the
balance between dendritic cells and monocytes during
development. The combination of genome editing and
scRNA-seq profiling provides a powerful tool for high-
throughput dissection of gene functions and will have a
wide range of applications in biomedical research.
Disease applications
Genomic profiling has been widely used to identify
markers, mechanisms, and therapeutic targets of diseases.
Most studies to date identify disease-related alterations bycomparing genomic profiles obtained from bulk disease
samples and their normal counterparts. However, these
average profiles provide a distorted view of the disease sam-
ple if it contains significant cellular heterogeneity, as in can-
cer. Single-cell technologies have provided a set of powerful
tools to dissect cellular heterogeneity and which have led to
important discoveries in cancer [23, 86–89] and other dis-
eases [90, 91]. For example, multiplexing quantitative poly-
merase chain reaction analysis has identified subtypes of
leukemia cells with distinct capacities for proliferation
[87, 92]. Application of scRNA-seq to cancer also led to
identification of rare subpopulations associated with
drug resistance [23] or self-renewal [89], whereas
scDNA-seq can be used to reconstruct paths of clonal
evolution [21]. Single-cell profiling will provide new op-
portunities for mechanistic understanding of the initiation
and progression of human diseases and to develop novel
treatment methods targeting specific cell types.
Interdisciplinary research
We recognize that to overcome each challenge requires
significant lab and computational infrastructure resources.
To move forward, the field needs groups of people with
diverse expertise to work together. Interdisciplinary ap-
proaches are recognized to be important, if not a crucial
prerequisite, for addressing many open questions, but also
come with numerous challenges. First, the lack of expert-
ise for parts of an interdisciplinary collaboration requires
increased effort and communication. The importance of a
common language is well known, but remains a significant
problem in almost every new project. Ideally, this hurdle
will be overcome by a new generation of students and
postdocs who are educated in multiple disciplines like
biology/medicine, engineering, and theoretical sciences.
Interdisciplinary science, while leading to higher long-
term impact, tends to be slower and published in journals
of lesser impact [93] and is hard to organize and fund.
Thus, it needs more patience, in particular in environ-
ments with funding cycles that require fast, short-term
output. Finally, not only language, but also career paths,
scientific and publication cultures, hiring procedures and
age, and scientific talent, and academic motivation vary
widely across disciplines. While many of these differences
pose managerial challenges and should not impact scien-
tific merit, in reality they often are the reason for failures
of interdisciplinary endeavors. Overcoming these prob-
lems will require changes in teaching, funding, and publi-
cation and hiring procedures, which would benefit most
areas of science, but will only have a measurable effect
after a few years.
Conclusions
Single-cell analysis is an exciting and rapidly expanding
field that holds tremendous potential to improve our
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help us to better understand the nature and complexity
of human disease in order to develop more effective
therapies. To achieve these ambitious goals, proper con-
trol needs to be taken to warrant the detection of genu-
ine heterogeneity existing in cell populations and tissue
samples. In addition, we need to invest in development
of new methods. Single-cell data present a number of in-
trinsic challenges, including systematic noise, the fea-
tures of biological systems, and the sparsity and
complexity of the data. The past few years have wit-
nessed remarkable growth in the field, a trend we believe
will continue, enabling more rigorous development of
methods and deeper understanding of biological
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